Tsushima, Hiroshi <br/><br/>
Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.  [electronic resource] 

 -  Autoimmunity  Aug 2017 
 - 329-335 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1607-842X 
<br/><br/><label>Standard No.: </label>10.1080/08916934.2017.1344970  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Rheumatoid--drug therapy<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>Female<br/>Humans<br/>Insulin-Like Growth Factor I--metabolism<br/>Macrophage Colony-Stimulating Factor--metabolism<br/>Mice<br/>Neovascularization, Pathologic--metabolism<br/>Osteoclasts--cytology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidines--pharmacology<br/>Pyrroles--pharmacology<br/>RANK Ligand--metabolism<br/>Receptor, IGF Type 1<br/>Receptors, Somatomedin--antagonists & inhibitors<br/>Signal Transduction--drug effects